These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9458351)

  • 1. Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5' CpG island.
    Saito Y; Takazawa H; Uzawa K; Tanzawa H; Sato K
    Int J Oncol; 1998 Feb; 12(2):293-8. PubMed ID: 9458351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas.
    Nakayama S; Sasaki A; Mese H; Alcalde RE; Tsuji T; Matsumura T
    Int J Cancer; 2001 Sep; 93(5):667-73. PubMed ID: 11477576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma.
    Yeh KT; Shih MC; Lin TH; Chen JC; Chang JY; Kao CF; Lin KL; Chang JG
    Anticancer Res; 2002; 22(6C):3971-5. PubMed ID: 12553020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
    Chang HW; Chow V; Lam KY; Wei WI; Yuen A
    Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
    Chen Q; Lipkina G; Song Q; Kramer RH
    Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of E-cadherin by promoter hypermethylation in oral carcinoma cells.
    Maeda G; Chiba T; Aoba T; Imai K
    Odontology; 2007 Jul; 95(1):24-9. PubMed ID: 17660978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer.
    de Moraes RV; Oliveira DT; Landman G; de Carvalho F; Caballero O; Nonogaki S; Nishimoto I; Kowalski LP
    Head Neck; 2008 Jan; 30(1):85-92. PubMed ID: 17685455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
    Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
    J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN; Xu CP; Han B; Ji R
    Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
    Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
    Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defected expression of E-cadherin in non-small cell lung cancer.
    Fei Q; Zhang H; Chen X; Wang JC; Zhang R; Xu W; Zhang Z; Zou W; Zhang K; Qi Q; Wang M; Tao S; Luo Z
    Lung Cancer; 2002 Aug; 37(2):147-52. PubMed ID: 12140137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas.
    Huang MJ; Yeh KT; Shih HC; Wang YF; Lin TH; Chang JY; Shih MC; Chang JG
    Int J Mol Med; 2002 Nov; 10(5):551-4. PubMed ID: 12373290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
    Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
    Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin.
    Kudo Y; Kitajima S; Ogawa I; Hiraoka M; Sargolzaei S; Keikhaee MR; Sato S; Miyauchi M; Takata T
    Clin Cancer Res; 2004 Aug; 10(16):5455-63. PubMed ID: 15328184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
    Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
    Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
    Viswanathan M; Tsuchida N; Shanmugam G
    Int J Cancer; 2003 May; 105(1):41-6. PubMed ID: 12672028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells.
    Si HX; Tsao SW; Lam KY; Srivastava G; Liu Y; Wong YC; Shen ZY; Cheung AL
    Cancer Lett; 2001 Nov; 173(1):71-8. PubMed ID: 11578811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.